Resource
|
Organisation
|
TGHN parent page
|
| COVID-19 Research Priorities Identified by the Global Research Community |
TGHN |
Covid Hub Mainpage |
| Coronavirus disease (COVID-2019) R&D Blueprint |
WHO |
Intervention Trials |
| COVID-19 Therapeutic Trial Synopsis |
WHO |
Intervention Trials |
| Outline of trial designs for experimental therapeutics |
WHO |
Intervention Trials |
| Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection |
WHO |
Intervention Trials |
| Outline of designs for experimental vaccines and therapeutics |
WHO |
Intervention Trials |
| Outline of designs for experimental vaccines and therapeutics |
WHO |
Intervention Trials |
| Overview of the types/classes of candidate therapeutics |
WHO |
Intervention Trials |
| International Clinical Trials Registry Platform |
WHO |
Intervention Trials |
| Database of publications on coronavirus disease (COVID-19) |
WHO |
Intervention Trials |
| Interim User Guide for COVID-19 |
CDISC |
Intervention Trials |
| Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic |
EMA |
Intervention Trials |
| Experimental Agent Reviews |
SIDP |
Intervention Trials |
| Assessment of Evidence for COVID-19-Related Treatments |
ASHP |
Intervention Trials |
| COVID-19 and Pharmacotherapy |
TRC Healthcare |
Intervention Trials |
| Detailed recommendations for interactions with experimental COVID-19 therapies |
University of Liverpool |
Intervention Trials |
| At-a-glance summary of interactions with experimental COVID-19 therapies |
University of Liverpool |
Intervention Trials |
| Administration in cases of swallowing difficulties |
University of Liverpool |
Intervention Trials |
| Veridata EDC |
Elsevier |
Intervention Trials |
| WHO database of publications on coronavirus disease (COVID-19) |
WHO |
Intervention Trials |
| Ongoing Clinical Trials for the Management of the COVID-19 Pandemic |
WHO |
Intervention Trials |
| An updated guide to the coronavirus drugs and vaccines in development |
WHO |
Intervention Trials |
| Therapeutic options for the 2019 novel coronavirus (2019-nCoV) |
WHO |
Intervention Trials |
| International Pulmonologist's Consensus on COVID-19 |
WHO |
Intervention Trials |
|
COVID-19 Drug Therapy - Potential Options
|
WHO |
Intervention Trials |
| COVID-19 science report: Therapeutics |
WHO |
Intervention Trials |
| COVID-19 trials registered up to 8 March 2020—an analysis of 382 studies |
WHO |
Intervention Trials |
| COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics |
WHO |
Intervention Trials |
| COVID-19 — The Search for Effective Therapy |
WHO |
Intervention Trials |
| LitCOVID |
PubMed |
Intervention Trials |
| Portfolio of resources |
ISARIC |
Intervention Trials |
